ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.652,52
-1,11%
S&P 500
5.011,12
-0,22%
Dow Jones
37.775,38
0,06%
Euro vs US Dollar
1,06491
0,05%
Bitcoin
64.614,75
1,74%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. West Pharmaceutical Services Inc (WST)

  7. West Pharmaceutical Services Inc (WST) News

WST West Pharmaceutical Services Inc

377,33
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:02:11
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
West Pharmaceutical Services Inc WST NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 377,33 10:02:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
377,33
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.4.202412:00PRNUSWest to Host First-Quarter 2024 Conference Call
01.3.202422:24EDGAR2Form PRE 14A - Other preliminary proxy statements
01.3.202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202422:30PRNUSWest to Participate in Upcoming Investor Conferences
27.2.202422:23EDGAR2Form 144 - Report of proposed sale of securities
27.2.202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:44EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20.2.202412:00PRNUSWest Announces Second-Quarter 2024 Dividend
15.2.202413:51EDGAR2Form 8-K - Current report
15.2.202412:00PRNUSWest Announces Fourth-Quarter and Full-Year 2023 Results
07.2.202414:00PRNUSWest Named to Newsweek's America's Greatest Workplaces 2024..
01.2.202412:00PRNUSWest to Host Fourth-Quarter and Full-Year 2023 Conference..
24.1.202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21.12.202318:54EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
13.12.202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202321:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202312:00PRNUSWest Announces First-Quarter 2024 Dividend
06.12.202301:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202321:46DJNWest Gets FDA 510(k) Clearance for Vial2Bag Advanced 13mm..
04.12.202321:00PRNUSWest Receives FDA 510(k) Clearance for Vial2Bag Advanced®..
30.11.202322:05EDGAR2Form 8-K - Current report
13.11.202313:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
02.11.202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202311:00PRNUSWest to Participate in Upcoming Investor Conferences
26.10.202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26.10.202313:41EDGAR2Form 8-K - Current report
26.10.202312:00PRNUSWest Announces Third-Quarter 2023 Results, Updates Full-Year..
23.10.202312:00PRNUSWest to Attend and Showcase Industry Leadership in Packaging..
16.10.202312:00PRNUSWest to Present on Development of Large Volume Delivery..
12.10.202312:00PRNUSWest to Host Third-Quarter 2023 Conference Call
21.9.202322:33EDGAR2Form 8-K/A - Current report: [Amend]
07.9.202312:00PRNUSWest to Participate in Upcoming Investor Conference
01.9.202321:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202323:58EDGAR2Form 144 - Report of proposed sale of securities
08.8.202321:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NYSE
WST
West Pharmaceutical Serv...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten